Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Diffuse CNS vasculopathy with chronic Epstein-Barr virus infection in X-linked lymphoproliferative disease.

Literature DB >> 16611784

Diffuse CNS vasculopathy with chronic Epstein-Barr virus infection in X-linked lymphoproliferative disease.

J K Weeks¹, K J Helton, M E Conley, M Onciu, R B Khan.

Abstract

We report a patient with X-linked lymphoproliferative disease (XLP) who developed multiple central nervous system (CNS) manifestations of Epstein-Barr virus infection. XLP, or Duncan syndrome, is a rare inherited disorder characterized by the inability to clear Epstein-Barr virus infection. In addition to Epstein-Barr virus encephalitis, CNS lymphoproliferative disease, and lymphoma, this patient also developed MR angiographic evidence of diffuse fusiform aneurysmal dilation of intracranial vessels.

Entities: Disease Species

Mesh：

Year: 2006 PMID： 16611784 PMCID： PMC8133978

Source DB: PubMed Journal: AJNR Am J Neuroradiol ISSN： 0195-6108 Impact factor: 3.825

12 in total

1. Survival is prolonged by highly active antiretroviral therapy in AIDS patients with primary central nervous system lymphoma.

Authors: Daniel J Skiest; Craig Crosby
Journal: AIDS Date: 2003-08-15 Impact factor: 4.177

Review 2. Large-vessel arteritis associated with chronic active Epstein-Barr virus infection.

Authors: K Murakami; M Ohsawa; S X Hu; H Kanno; K Aozasa; M Nose
Journal: Arthritis Rheum Date: 1998-02

3. Lymphocytic vasculitis in X-linked lymphoproliferative disease.

Authors: J P Dutz; L Benoit; X Wang; D J Demetrick; A Junker; D de Sa; R Tan
Journal: Blood Date: 2001-01-01 Impact factor: 22.113

4. Necrotizing lymphoid vasculitis in X-linked lymphoproliferative syndrome.

Authors: S Loeffel; C H Chang; R Heyn; S Harada; H Lipscomb; F Sinangil; D J Volsky; K McClain; H Ochs; D T Purtilo
Journal: Arch Pathol Lab Med Date: 1985-06 Impact factor: 5.534

5. Salvage chemotherapy with temozolomide in primary CNS lymphomas: preliminary results of a phase II trial.

Authors: Michele Reni; Warren Mason; Francesco Zaja; James Perry; Enrico Franceschi; Daniele Bernardi; Stefania Dell'Oro; Caterina Stelitano; Marco Candela; Antonio Abbadessa; Andrea Pace; Roberto Bordonaro; Giancarlo Latte; Eugenio Villa; Andrés J M Ferreri
Journal: Eur J Cancer Date: 2004-07 Impact factor: 9.162

6. Malignant lymphoma in the X-linked lymphoproliferative syndrome.

Authors: D S Harrington; D D Weisenburger; D T Purtilo
Journal: Cancer Date: 1987-04-15 Impact factor: 6.860

7. Epstein-Barr virus encephalitis and encephalomyelitis: MR findings.

Authors: W J Shian; C S Chi
Journal: Pediatr Radiol Date: 1996-09

Review 8. Two cases of cerebral aneurysms in HIV+ children.

Authors: B B Fulmer; S C Dillard; E M Musulman; C A Palmer; J Oakes
Journal: Pediatr Neurosurg Date: 1998-01 Impact factor: 1.162

Review 9. X-linked lymphoproliferative disease: twenty-five years after the discovery.

Authors: T A Seemayer; T G Gross; R M Egeler; S J Pirruccello; J R Davis; C M Kelly; M Okano; A Lanyi; J Sumegi
Journal: Pediatr Res Date: 1995-10 Impact factor: 3.756

10. Host response to EBV infection in X-linked lymphoproliferative disease results from mutations in an SH2-domain encoding gene.

Authors: A J Coffey; R A Brooksbank; O Brandau; T Oohashi; G R Howell; J M Bye; A P Cahn; J Durham; P Heath; P Wray; R Pavitt; J Wilkinson; M Leversha; E Huckle; C J Shaw-Smith; A Dunham; S Rhodes; V Schuster; G Porta; L Yin; P Serafini; B Sylla; M Zollo; B Franco; A Bolino; M Seri; A Lanyi; J R Davis; D Webster; A Harris; G Lenoir; G de St Basile; A Jones; B H Behloradsky; H Achatz; J Murken; R Fassler; J Sumegi; G Romeo; M Vaudin; M T Ross; A Meindl; D R Bentley
Journal: Nat Genet Date: 1998-10 Impact factor: 38.330

11 in total

1. The vascular effects of infection in Pediatric Stroke (VIPS) Study.

Authors: Heather J Fullerton; Mitchell S V Elkind; A James Barkovich; Carol Glaser; David Glidden; Nancy K Hills; Carlos Leiva-Salinas; Max Wintermark; Gabrielle A Deveber
Journal: J Child Neurol Date: 2011-05-25 Impact factor: 1.987

Review 2. Pediatric Stroke Imaging.

Authors: Alexander Khalaf; Michael Iv; Heather Fullerton; Max Wintermark
Journal: Pediatr Neurol Date: 2018-07-09 Impact factor: 3.372

3. A Novel RAC2 Mutation Causing Combined Immunodeficiency.

Authors: Liang Zhang; Ge Lv; Yu Peng; Lu Yang; Junjie Chen; Yunfei An; Zhiyong Zhang; Xuemei Tang; Zhihui Li; Xiaodong Zhao
Journal: J Clin Immunol Date: 2022-10-03 Impact factor: 8.542

4. Lymphocytic vasculitis involving the central nervous system occurs in patients with X-linked lymphoproliferative disease in the absence of Epstein-Barr virus infection.

Authors: Kawsar R Talaat; Jennifer A Rothman; Jeffrey I Cohen; Mariarita Santi; John K Choi; Miguel Guzman; Robert Zimmerman; Sudha Nallasamy; Alexander Brucker; Martha Quezado; Stefania Pittaluga; Nicholas J Patronas; Amy D Klion; Kim E Nichols
Journal: Pediatr Blood Cancer Date: 2009-12 Impact factor: 3.167

5. Herpesvirus Infections and Childhood Arterial Ischemic Stroke: Results of the VIPS Study.

Authors: Mitchell S V Elkind; Nancy K Hills; Carol A Glaser; Warren D Lo; Catherine Amlie-Lefond; Nomazulu Dlamini; Rachel Kneen; Eldad A Hod; Max Wintermark; Gabrielle A deVeber; Heather J Fullerton
Journal: Circulation Date: 2016-01-26 Impact factor: 29.690

6. Predictors of cerebral arteriopathy in children with arterial ischemic stroke: results of the International Pediatric Stroke Study.

Authors: Catherine Amlie-Lefond; Timothy J Bernard; Guillaume Sébire; Neil R Friedman; Geoffrey L Heyer; Norma B Lerner; Gabrielle DeVeber; Heather J Fullerton
Journal: Circulation Date: 2009-03-02 Impact factor: 29.690